Although the use of bioabsorbable occluder is expected to reduce the risk of metal occluder-
related complications, it has not been approved due to incomplete degradation and new …

This multicenter study assessed the efficacy and safety of transcatheter closure of
perimembranous ventricular septal defect (VSD) using a modified double-disk occluder. In 5 …

Background: Transcatheter closure of perimembranous ventricular septal defects is
challenging. Double disk-designed devices have high adverse event rates; therefore …

Background Transcatheter closure of perimembranous ventricular septal defects is one of
the greatest challenges in interventional cardiology. Short-and midium-term follow-up data …

Percutaneous closure is the standard therapy for muscular Ventricular Septal Defects
(VSDs) beyond infancy with a low rate of major complications. The story is somewhat …

Background: Heart block is the most common and concerning complication associated with
transcatheter device closure of perimembranous ventricular septal defect (pmVSD) and its …

Objectives To evaluate the safety, efficiency, and midterm outcomes of transcatheter
perimembranous ventricular septal defect (pmVSD) closure using the new KONAR‐MF™ …

Background: Potential differences in complications and/or long-term outcomes of
perimembranous ventricular septal defect (pmVSD) closures with 3-mm waist vs. 4-mm waist …

Objective Percutaneous closure of perimembranous ventricular septal defect is one of the
greatest challenges in interventional cardiology. The long‐term follow‐up data are still …

Objectives: This study assessed the feasibility and efficacy of implanting a new nitinol device
for closure of perimembranous ventricular septal defects in a swine model. Background …